Research Papers

25 of 729 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Classification of new morbillivirus and jeilongvirus sequences from bats sampled in Brazil and Malaysia.
Wells HL; Loh E; Nava A; Solorio MR; Lee MH; Lee J; Sukor JRA; Navarrete-Macias I; Liang E; Firth C; Epstein JH; Rostal MK; Zambrana-Torrelio C; Murray K; Daszak P; Goldstein T; Mazet JAK; Lee B; Hughes T; Durigon E; Anthony SJ.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Mechanisms of host type I interferon response modulation by the nucleocapsid proteins of alpha- and betacoronaviruses.
Yelemali P; Hao L; Liu Q.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Predominance and first complete genomic characterization of canine parvovirus 2b in Turkey.
Abayli H; Aslan O; Tumer KC; Can-Sahna K; Tonbak S.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies.
Kumar S; Verma A; Yadav P; Dubey SK; Azhar EI; Maitra SS; Dwivedi VD.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Distribution of equine coronavirus RNA in the intestinal and respiratory tracts of experimentally infected horses.
Kambayashi Y; Kishi D; Ueno T; Ohta M; Bannai H; Tsujimura K; Kinoshita Y; Nemoto M.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Reverse-zoonotic transmission of SARS-CoV-2 lineage alpha (B.1.1.7) to great apes and exotic felids in a zoo in the Cze…
Nagy A; Stará M; Vodička R; Černíková L; Jiřincová H; Křivda V; Sedlák K.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro.
Ngwe Tun MM; Luvai E; Nwe KM; Toume K; Mizukami S; Hirayama K; Komatsu K; Morita K.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon.
Bahlawan O; Badra R; Semaan H; Fayad N; Kamel MN; El Taweel AN; Gomaa MR; Sirawan A; Berry A; Mokhbat J; Goldstein J; Abdallah J; Kayali G.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Complete genome sequence of a novel potyvirus infecting Miscanthus sinensis (silver grass).
Leblanc Z; Gauthier ME; Lelwala R; Elliott C; McMaster C; Eichner R; Davis K; Liefting L; Thompson J; Dinsdale A; Whattam M; Pattemore J; Barrero RA.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Analysis and optimization of a Caco-2 cell culture model for infection with human norovirus.
Pohl C; Szczepankiewicz G; Liebert UG.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Biological and molecular characterization of fEg-Eco19, a lytic bacteriophage active against an antibiotic-resistant cl…
Badawy S; Baka ZAM; Abou-Dobara MI; El-Sayed AKA; Skurnik M.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Complete genome sequence of a novel porcine hemagglutinating encephalomyelitis virus strain identified in South Korea.
Kim Y; Lee KM; Jang G; Lee C.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Human-stool-associated tusavirus (Parvoviridae) in domestic goats and sheep.
Reuter G; Pankovics P; László Z; Gáspár G; Hui A; Delwart E; Boros Á.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
A decontamination strategy for resolving SARS-CoV-2 amplicon contamination in a next-generation sequencing laboratory.
Mwangi P; Mogotsi M; Ogunbayo A; Mooko T; Maringa W; Sondlane H; Nkwadipo K; Adelabu O; Bester PA; Goedhals D; Nyaga M.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug de…
Shoja Z; Jalilvand S; Latifi T; Roohvand F.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A novel parvovirus (family Parvoviridae) in a freshwater fish, zander (Sander lucioperca).
Reuter G; Boros Á; Mátics R; Altan E; Delwart E; Pankovics P.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Temporal expression of defence and susceptibility genes and tospovirus accumulation in capsicum chlorosis virus-infecte…
Borges Naito FY; Widana Gamage SMK; Mitter N; Dietzgen RG.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
First report of canine bufavirus in India.
Ganji VK; Buddala B; Yella NR; Putty K.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Development of an immunofluorescence assay for detection of SARS-CoV-2.
Atiya-Nasagi Y; Milrot E; Makdasi E; Schuster O; Shmaya S; Simon I; Ben-Shmuel A; Beth-Din A; Weiss S; Laskar O.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predi…
Wang Y; Li P; Lavrijsen M; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Diagnostic performance and clinical feasibility of a novel one-step RT-qPCR assay for simultaneous detection of multipl…
Le TB; Kim HK; Ahn MJ; Zanin M; Lo VT; Ling S; Jiang Z; Kang JA; Bae PK; Kim YS; Kim S; Wong SS; Jeong DG; Yoon SW.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Autophagy inhibitors alleviate Japanese encephalitis virus-induced cerebral inflammation in mice.
Zhang J; Han W; Xie C; Gao M; Wang X; Hu X; Zhang W; Cao S; Liu X; Cheng G; Gu C.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Complete genome sequence of a novel bat mastadenovirus C strain isolated from Rhinolophus cornutus in Japan.
Katayama M; Murakami S; Matsugo H; Kamiki H; Fujii M; Takenaka-Uema A; Horimoto T.
Arch Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections.
Meshram RJ; Kathwate GH; Gacche RN.
Arch Virol (Unknown)
Published: 2022
2/6 Transparent
The ins and outs of SARS-CoV-2 variants of concern (VOCs).
Salehi-Vaziri M; Fazlalipour M; Seyed Khorrami SM; Azadmanesh K; Pouriayevali MH; Jalali T; Shoja Z; Maleki A.
Arch Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared